Increased Levels of Cell-Free miR-517a and Decreased Levels of Cell-Free miR-518b in Maternal Plasma Samples From Placenta Previa Pregnancies at 32 Weeks of Gestation

Abstract

Objective:

The aim of this study was to clarify the association between placenta previa and circulating levels of cell-free pregnancy-associated placenta-specific microRNAs (miRNAs) in maternal plasma.

Method:

Twenty singleton pregnancies with placenta previa (placenta previa group) and 26 uncomplicated pregnancies (control group) were recruited. Blood sampling was performed at 32 weeks of gestation, and cesarean delivery in all cases of placenta previa was performed at a mean gestational age of 37 weeks. The maternal plasma concentrations of cell-free pregnancy-associated placenta-specific miRNAs (miR-517a and miR-518b) were measured by absolute quantitative real-time reverse transcription-polymerase chain reaction.

Results:

Plasma concentrations of cell-free miR-517a were significantly higher in the placenta previa group than that in the control group (P = .011), while the plasma concentration of cell-free miR-518b was significantly lower in the placenta previa group than that in the control group (P = .004). Plasma concentrations of cell-free miR-517a in placenta previa were significantly higher in placenta previa with alert bleeding later group than those in placenta previa without alert bleeding group or control group (P = .030 or .047, respectively) and correlated with the volume of hemorrhage at delivery (R and P value: .512 and .025).

Conclusion:

Plasma concentrations of cell-free miR-517a and miR-518b at 32 weeks of gestation were altered in pregnant women with placenta previa, and the circulating level of cell-free miR-517a in placenta previa may be a predictive marker for the risks of alert bleeding later and massive hemorrhage at delivery.

Keywords

pregnancy-associated microRNA maternal plasma placenta previa alert bleeding hemorrhage

Get full access to this article

View all access options for this article.

References

Oyelese

Smulian

. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol. 2006;107(4):927–941.

Baba

Matsubara

Ohkuchi

. Anterior placentation as a risk factor for massive hemorrhage during cesarean section in patients with placenta previa. J Obstet Gynaecol Res. 2014;40(5):1243–1248.

Hasegawa

Nakamura

Hamada

. Prediction of hemorrhage in placenta previa. Taiwan J Obstet Gynecol. 2012;51(1):3–6.

Ghourab

. Third-trimester transvaginal ultrasonography in placenta previa: does the shape of the lower placental edge predict clinical outcome? Ultrasound Obstet Gynecol 2001;18(2):103–108.

Zaitoun

El Behery

Abd

Soliman

. Does cervical length and the lower placental edge thickness measurement correlates with clinical outcome in cases of complete placenta previa? Arch Gynecol Obstet. 2011;284(4):867–873.

Chim

Shing

Hung

. Detection and characterization of placental microRNAs in maternal plasma. Clin Chem. 2008;54(3):482–490.

Chiu

. Pregnancy-associated microRNAs in maternal plasma: a channel for fetal–maternal communication? Clin Chem. 2010;56(11):1656–1657.

Miura

Yamasaki

. Identification of pregnancy-associated microRNAs in maternal plasma. Clin Chem. 2010;56(11):1767–1771.

Donker

Mouillet

Chu

. The expression profile of C19MC microRNAs in primary human trophoblast cells and exosomes. Mol Hum Reprod. 2012;18(8):417–424.

10.

Luo

Ishibashi

Ishikawa

. Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol Reprod. 2009;81(4):717–729.

11.

Hromadnikova

Kotlabova

Ondrackova

. Circulating C19MC microRNAs in preeclampsia, gestational hypertension, and fetal growth restriction. Mediators Inflamm. 2013;2013:186041.

12.

Mouillet

Chu

Sadovsky

. Expression patterns of placental microRNAs. Birth Defects Res A Clin Mol Teratol. 2011;91(8):737–743.

13.

Chiu

Poon

Lau

. Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem. 2001;47(9):1607–1613.

14.

Bentwich

Avniel

Karov

. Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet. 2005;37(7):766–770.

15.

Liang

Ridzon

Wong

Chen

. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics. 2007;8:166.

16.

Bortolin-Cavaillé

Dance

Weber

Cavaillé

. C19MC microRNAs are processed from introns of large Pol-II, non-protein-coding transcripts. Nucleic Acids Res. 2009;37(10):3464–3473.

17.

Morales-Prieto

Ospina-Prieto

Chaiwangyen

Schoenleben

Markert

. Pregnancy-associated miRNA-clusters. J Reprod Immunol. 2013;97(1):51–61.

18.

Morales Prieto

Markert

. MicroRNAs in pregnancy. J Reprod Immunol. 2011;88(2):106–111.

19.

Higashijima

Miura

Mishima

. Characterization of placenta-specific microRNAs in fetal growth restriction pregnancy. Prenat Diagn. 2013;33(3):214–222.

20.

Hasegawa

Miura

Furuya

Yoshiura

Masuzaki

. Identification of complete hydatidiform mole pregnancy-associated microRNAs in plasma. Clin Chem. 2013;59(9):1410–1412.

21.

Mouillet

Chu

Sadovsky

. Expression patterns of placental microRNAs. Birth Defects Res A Clin Mol Teratol. 2011;91(8):737–743.

22.

Zhao

Moley

Gronowski

. Diagnostic potential for miRNAs as biomarkers for pregnancy-specific diseases. Clin Biochem. 2013;46(10-11):953–960.

23.

Tsui

Lam

. Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin Chem. 2002;48(8):1212–1217.

24.

Miura

Yamasaki

. Increased level of cell-free placental mRNA in a subgroup of placenta previa that needs hysterectomy. Prenat Diagn. 2008;28(9):805–809.

25.

Knight

Redman

Linton

Sargent

. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol. 1998;105(6):632–640.

26.

Wang

Song

. Altered expression of miR-518b and miR-519a in the placenta is associated with low fetal birth weight. Am J Perinatol. 2014;31(9):729–734.

27.

Samuel

Bonanno

Oliphant

. Fraction of cell-free fetal DNA in the maternal serum as a predictor of abnormal placental invasion: a pilot study. Prenat Diagn. 2013;33(11):1050–1053.

28.

Kawashima

Sekizawa

Ventura

. Increased levels of cell-free human placental lactogen mRNA at 28-32 gestational weeks in plasma of pregnant women with placenta previa and invasive placenta. Reprod Sci. 2014;21(2):215–220.